Additional file 1: of Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)

Murray, Macey; Meadows, Jade; DorĂŠ, Caroline; Copas, Andrew; Haddow, Lewis; Lacey, Charles; Jit, Mark; Soldan, Kate; Bennett, Kate; Tetlow, Michelle; Nathan, Mayura; Gilson, Richard

doi:10.6084/m9.figshare.7305449.v1

12874_2018_581_MOESM1_ESM.docx (14.93 kB)

Additional file 1: of Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)

journal contribution

posted on 2018-11-06, 05:00 authored by Macey Murray, Jade Meadows, Caroline DorĂŠ, Andrew Copas, Lewis Haddow, Charles Lacey, Mark Jit, Kate Soldan, Kate Bennett, Michelle Tetlow, Mayura Nathan, Richard Gilson

Participating sites. (DOCX 14 kb)

Funding

Health Technology Assessment Programme

History

Usage metrics

Keywords

Podophyllotoxin Imiquimod Quadrivalent HPV vaccine Human papillomavirus Anogenital warts

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC